Three new streptococcal M serotypes, types 59, 60, and 61, have been described. They were first isolated from patients with pyoderma and acute glomerulonephritis (AGN), seen during epidemiological studies in Alabama Epidemiological studies of pyoderma and acute glomerulonephritis (AGN) were initiated in this laboratory a decade ago. At that time, little was known regarding M antigens of the common pyoderma streptococci (16, 17), and only one known M serotype, type 49, was associated with AGN following pyoderma (24). Few strains of streptococci could be serotyped with the then available reference M antisera, and antisera for T-agglutination typing were not available from the National Center for Disease Control (NCDC) Streptococcal Laboratory. To pursue definitive epidemiological studies, a collaborative investigation with M. Moody at the NCDC and W. Maxted and M. Parker at the Central Public Health Laboratory (CPHL), Colindale, London, was undertaken. A sizable collection of strains from pyoderma and associated cases of AGN studied in Alabama during the years 1964 through 1966 were examined (4). Most strains were classified only by their T antigens and, with the exception of certain nephritogenic serotypes, the T-agglutination patterns commonly encountered were like those Parker and co-workers described as "impetigo streptococci" (16, 17) .
Epidemiological studies of pyoderma and acute glomerulonephritis (AGN) were initiated in this laboratory a decade ago. At that time, little was known regarding M antigens of the common pyoderma streptococci (16, 17) , and only one known M serotype, type 49, was associated with AGN following pyoderma (24) . Few strains of streptococci could be serotyped with the then available reference M antisera, and antisera for T-agglutination typing were not available from the National Center for Disease Control (NCDC) Streptococcal Laboratory. To pursue definitive epidemiological studies, a collaborative investigation with M. Moody at the NCDC and W. Maxted and M. Parker at the Central Public Health Laboratory (CPHL), Colindale, London, was undertaken. A sizable collection of strains from pyoderma and associated cases of AGN studied in Alabama during the years 1964 through 1966 were examined (4) . Most strains were classified only by their T antigens and, with the exception of certain nephritogenic serotypes, the T-agglutination patterns commonly encountered were like those Parker and co-workers described as "impetigo streptococci" (16, 17) .
In subsequent studies in our laboratory, the majority of nephritogenic serotypes from pyoderma-associated cases were classified as either M-49 or M-2, the latter having the agglutination pattern 8/25/Imp.19 rather than the T-2 antigen (3). However, a sizable collection of pyoderma strains, including certain ones associated with AGN, remained non-M-typable.
We are now reporting the isolation and characterization of three new streptococcal M serotypes, types 59, 60, and 61, each of which was initially isolated from patients with pyoderma and AGN. Their biological character and epidemiological significance are described. Lancefield (Table  1) . They were distinguished from other strains in our collection found by agglutination to be T-4/28 and from those T-4 strains shown to be M-type 4, a type infrequently encountered in pyoderma but common in acute pharyngitis. The relationship between the type 60 vaccine strains and AGN following pyoderma first stimulated our interest in them. Antisera were easily prepared with both vaccine strains, and reciprocal precipitin and bactericidal tests indicated that they were identical. Type 2797-S was chosen as the reference type strain. Indirect bactericidal tests comparing 2797-S (type 60) with a type 4 strain isolated from a patient with acute pharyngitis are illustrated in Table 6 . The latter proved superior in bactericidal tests to the type 4 vaccine strain obtained from the NCDC. The results clearly demonstrated type 60 to be distinct from type 4. When type 4 and M-4 antisera from Lancefield were used in reciprocal tests, similar results confirming the specificity of type 60 were obtained. Reciprocal indirect bactericidal tests were also done with Table 8 . Agglutination reactions with reference antisera and the newly prepared agglutination sera are included, and M types are arranged in relation to these results. Ninety strains were agglutinated with the "T-59" antiserum, and 70 of the 90 were proven to be M-type 59. Additional strains not listed which were negative with both the agglutination and precipitin antisera for type 59 included 83 T-12, non-M-typable strains and 47 others identified by agglutination only as members of the 5/27/44 agglutination complex. Type 61 strains were limited to those agglutinated as T-11 or T-9/11. During this 3-year period, type 61 occurred with similar frequency to type 11; no other M type was identified among the strains sharing the T-11 or T-9/11 agglutination reaction. Type 60 strains were limited to those initially identified by agglutination as T-4; they were subsequently shown to be specifically agglutinated by the "T-60" agglutination antiserum. Type 60 strains were far more common than type 4 in this collection.
Additional, previously non-M-typable strains, most isolated from patients with AGN following pyoderma, who were seen either prior to 1966 or in 1969, were also reexamined with these new M antisera. A total of 19 type 60 strains, including 18 isolated prior to 1966, were identified in addition to those shown in Table 8 . Of the total of 48 type 60 strains found, 11 were from patients with pyoderma and nephritis and two others were from their sibling contacts. It was the most common of the three new types associated with AGN. A number of M types are now recognized to share antigens common to the 3/13/B3264 complex. Though infrequently incriminated in acute glomerulonephritis, these various types are most common among patients with uncomplicated impetigo (4, 15, 18, 23 Although disadvantages of the T-agglutination method for identifying group A streptococci, especially if used alone, are well recognized (12, 13, 21) , the initial characterization of these newly reported serotypes by their Tagglutination reaction was of immense value in first recognizing them and subsequently selecting possible candidates as vaccine strains. The utilization of both type 59 and type 60 agglutination antisera has proven of practical value in continuing epidemiological studies. Maxted et al. (11) demonstrated the value of a specific agglutination antiserum in distinguishing type 49 streptococci from related types which share the T-14 antigen. Thus, greater specificity for the T-agglutination method of serotyping appears feasible and is likely dependent upon the selection of new or more appropriate vaccine strains. Preliminary identification of strains by T-antigen analysis may narrow the range of M antisera required for initial M-typing of wild strains (12) (13) (14) (15) . More specific agglutination antisera would further enhance the value of this method and could result in more economical and efficient use of M antisera. In addition, such antisera could enhance and expedite epidemiological studies involving large numbers of streptococci.
Cumulative studies of pyoderma and nephritis have made it abundantly clear that the needs for given M antisera within a reference set vary in relation to the site of streptococcal infection being investigated. There is mounting evidence that a clear dichotomy exists between acute pharyngitis and pyoderma insofar as prevalent streptococcal M serotypes causing these infections are concerned (25; H. C. Dillon, Fifth Int. Symp. Streptococcus Pyogenes, in press). Vaccine strains for the earlier established types came largely from sources other than skin and soft tissue infection, with cases of acute pharyngitis and/or scarlet fever being the most frequent sources (13, 23 VOL. 9, 1974 
